GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Cano Health Inc (OTCPK:CANOQ) » Definitions » Beneish M-Score

Cano Health (Cano Health) Beneish M-Score : -0.81 (As of Apr. 28, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Cano Health Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Warning Sign:

Beneish M-Score -0.81 higher than -1.78, which implies that the company might have manipulated its financial results.

The historical rank and industry rank for Cano Health's Beneish M-Score or its related term are showing as below:

CANOQ' s Beneish M-Score Range Over the Past 10 Years
Min: -1.33   Med: -1.07   Max: -0.81
Current: -0.81

During the past 5 years, the highest Beneish M-Score of Cano Health was -0.81. The lowest was -1.33. And the median was -1.07.


Cano Health Beneish M-Score Historical Data

The historical data trend for Cano Health's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cano Health Beneish M-Score Chart

Cano Health Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Beneish M-Score
- - - -1.33 -0.81

Cano Health Quarterly Data
Dec19 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.33 -1.90 -2.40 -1.50 -0.81

Competitive Comparison of Cano Health's Beneish M-Score

For the Medical Care Facilities subindustry, Cano Health's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cano Health's Beneish M-Score Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Cano Health's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Cano Health's Beneish M-Score falls into.



Cano Health Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Cano Health for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.2249+0.528 * 6.0961+0.404 * 1.0382+0.892 * 1.1455+0.115 * 0.3883
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.7499+4.679 * -0.010851-0.327 * 2.139
=-0.81

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec23) TTM:Last Year (Dec22) TTM:
Total Receivables was $76 Mil.
Revenue was 716.028 + 788.073 + 766.746 + 866.909 = $3,138 Mil.
Gross Profit was 33.163 + 15.604 + -59.64 + 90.151 = $79 Mil.
Total Current Assets was $183 Mil.
Total Assets was $1,014 Mil.
Property, Plant and Equipment(Net PPE) was $133 Mil.
Depreciation, Depletion and Amortization(DDA) was $187 Mil.
Selling, General, & Admin. Expense(SGA) was $363 Mil.
Total Current Liabilities was $1,415 Mil.
Long-Term Debt & Capital Lease Obligation was $131 Mil.
Net Income was -165.028 + -260.487 + -140.753 + -28.15 = $-594 Mil.
Non Operating Income was -82.647 + -370.497 + 2.321 + -3.546 = $-454 Mil.
Cash Flow from Operations was -44.383 + -39.711 + -15.485 + -29.47 = $-129 Mil.
Total Receivables was $294 Mil.
Revenue was 680.373 + 665.028 + 689.373 + 704.337 = $2,739 Mil.
Gross Profit was 107.001 + 111.596 + 95.409 + 107.881 = $422 Mil.
Total Current Assets was $341 Mil.
Total Assets was $1,929 Mil.
Property, Plant and Equipment(Net PPE) was $309 Mil.
Depreciation, Depletion and Amortization(DDA) was $91 Mil.
Selling, General, & Admin. Expense(SGA) was $422 Mil.
Total Current Liabilities was $208 Mil.
Long-Term Debt & Capital Lease Obligation was $1,168 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(75.801 / 3137.756) / (294.216 / 2739.111)
=0.024158 / 0.107413
=0.2249

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(421.887 / 2739.111) / (79.278 / 3137.756)
=0.154023 / 0.025266
=6.0961

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (182.823 + 133.099) / 1013.739) / (1 - (340.748 + 309.217) / 1928.927)
=0.68836 / 0.663043
=1.0382

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=3137.756 / 2739.111
=1.1455

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(90.64 / (90.64 + 309.217)) / (186.64 / (186.64 + 133.099))
=0.226681 / 0.583726
=0.3883

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(362.81 / 3137.756) / (422.357 / 2739.111)
=0.115627 / 0.154195
=0.7499

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((131.373 + 1415.426) / 1013.739) / ((1167.517 + 208.438) / 1928.927)
=1.525836 / 0.713327
=2.139

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-594.418 - -454.369 - -129.049) / 1013.739
=-0.010851

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Cano Health has a M-score of -0.81 signals that the company is likely to be a manipulator.


Cano Health Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Cano Health's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Cano Health (Cano Health) Business Description

Traded in Other Exchanges
N/A
Address
9725 NW 117th Avenue, Suite 200, Miami, FL, USA, 33178
Cano Health Inc operates value-based primary care centers and supports affiliated medical practices that specialize in primary care for seniors in Florida, Texas, Nevada, and Puerto Rico.
Executives
Elliot Cooperstone director, 10 percent owner C/O CANO HEALTH, INC., 9725 NW 117TH AVENUE, SUITE 200, MIAMI FL 33178
Eladio Gil officer: Interim CFO 9725 NW 17TH AVENUE, SUITE 200, MIAMI FL 33178
Robert Camerlinck officer: Chief Operating Officer 9725 NW 117TH AVENUE, SUITE 200, MIAMI FL 33178
Richard Aguilar officer: Chief Clinical Officer 9725 NW 117TH AVENUE, SUITE 200, MIAMI FL 33178
Mark D. Kent officer: Interim CEO 9725 NW 117TH AVENUE, SUITE 200, MIAMI FL 33178
David J Armstrong officer: See Remarks 9725 NW 117TH AVENUE, SUITE 200, MIAMI FL 33178
Brian D Koppy officer: Chief Financial Officer 9725 NW 117TH AVENUE, SUITE 200, MIAMI FL 33178
Lewis Gold director 1235 SPANISH RIVER ROAD, BOCA RATON FL 33432
Marlow Hernandez director, officer: See Remarks 9725 NW 117TH AVENUE, SUITE 200, MIAMI FL 33178
Solomon D Trujillo director 1000 NICOLLET MALL, TPS-3255, MINNEAPOLIS MN 55403
Alan Muney director 48 MONROE TURNPIKE, TRUMBULL CT 06611
Kim M Rivera director 601 HAWAII ST, EL SEGUNDO CA 90245
Itc Rumba, Llc 10 percent owner 444 MADISON AVENUE, 35TH FLOOR, NEW YORK NY 10022
Jacqueline Guichelaar director C/O CANO HEALTH, INC., 9725 NW 117TH AVENUE, SUITE 200, MIAMI FL 33178
Angel L Morales director C/O CANO HEALTH, INC., 9725 NW 117TH AVENUE, SUITE 200, MIAMI FL 33178